Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Pelvic Neoplasms 2Breast Neoplasms 2Small Cell Lung Carcinoma 1Rectal Neoplasms 1Pancreatic Neoplasms 1Mesothelioma 1Malignant Solid Neoplasm 1Lung Neoplasms 1Leiomyoma 1Colorectal Neoplasms 1Colonic Polyps 1Colonic Neoplasms 1Chylous Ascites 1Carcinoma, Non-Small-Cell Lung 1Adenomyosis 1Abdominal Neoplasms 1

Interventions

Pemetrexed 22Cisplatin 20Nivolumab 8Gemcitabine 7Carboplatin 7durvalumab 5Ipilimumab 5Bevacizumab 5pembrolizumab 4Radiotherapy, Intensity-Modulated 4tremelimumab 3niraparib 3Oxaliplatin 3Drug Therapy 3Cyclophosphamide 3Cerebral Decortication 3Blood Specimen Collection 3sargramostim 2Thoracoscopy 2Surveys and Questionnaires 2Sorafenib 2Radiosurgery 2Magnesium Sulfate 2Leucovorin 2Imatinib Mesylate 2Hyperthermic Intraperitoneal Chemotherapy 2Doxorubicin 2Dexamethasone 2tislelizumab 1spartalizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Mesothelioma × Iohexol × Clear all
NCT01188486 2018-04-17

Pulmonary Interstitial Lymphography in Early Stage Lung Cancer

Stanford University

Phase NA Terminated
12 enrolled
Other solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Mesothelioma, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡